找回密碼
 To register

QQ登錄

只需一步，快速開始

掃一掃，訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cancer Proteomics; From Bench to Bedsid Sayed S. Daoud Book 2008 Humana Press 2008 Bioinformatics.Cancer Research.Carcinom.Oncology.Proteom

[復(fù)制鏈接]
查看: 55090|回復(fù): 46
樓主
發(fā)表于 2025-3-21 16:40:52 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Cancer Proteomics
副標(biāo)題From Bench to Bedsid
編輯Sayed S. Daoud
視頻videohttp://file.papertrans.cn/222/221184/221184.mp4
概述Comprehensive look at the use of proteomic strategies in cancer therapy.Covers all the latest technologies used in proteomics.Includes in-depth information on the human proteome and the role of the FD
叢書名稱Cancer Drug Discovery and Development
圖書封面Titlebook: Cancer Proteomics; From Bench to Bedsid Sayed S. Daoud Book 2008 Humana Press 2008 Bioinformatics.Cancer Research.Carcinom.Oncology.Proteom
描述.This book provides the reader with broad perspectives and breadth of knowledge on current topics related to the use of proteomic strategies in cancer therapy as well as anticipated challenges that may arise from its application in daily practice. The book is divided into 4 parts. The first part begins with the current technologies used in proteomics that allow for protein profiling and for the identification of druggable targets in human samples. Mass spectrometry based protein characterization and protein microarrays hold great promise of predicting response to specific drugs in cancer therapy. The second part deals with the use proteomics in cell signaling. At the present, the pharmaceutical and biotechnology industries have many potentially useful small molecule inhibitors of many pathways important in cancer that have yet to be taken to clinical trials. Understanding protein-protein interaction and posttranslational modifications through proteomics will likely make it much more feasible to do effective clinical trials of these small molecules alone and in combinations to overcome drug resistance and improve patient care. The third part of the book moves from signaling to actua
出版日期Book 2008
關(guān)鍵詞Bioinformatics; Cancer Research; Carcinom; Oncology; Proteomics; Translation; classification; diagnostics; p
版次1
doihttps://doi.org/10.1007/978-1-59745-169-7
isbn_softcover978-1-61737-807-2
isbn_ebook978-1-59745-169-7Series ISSN 2196-9906 Series E-ISSN 2196-9914
issn_series 2196-9906
copyrightHumana Press 2008
The information of publication is updating

書目名稱Cancer Proteomics影響因子(影響力)




書目名稱Cancer Proteomics影響因子(影響力)學(xué)科排名




書目名稱Cancer Proteomics網(wǎng)絡(luò)公開度




書目名稱Cancer Proteomics網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Cancer Proteomics被引頻次




書目名稱Cancer Proteomics被引頻次學(xué)科排名




書目名稱Cancer Proteomics年度引用




書目名稱Cancer Proteomics年度引用學(xué)科排名




書目名稱Cancer Proteomics讀者反饋




書目名稱Cancer Proteomics讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics
 

1票 100.00%

Better Implies Difficulty
 

0票 0.00%

Good and Satisfactory
 

0票 0.00%

Adverse Performance
 

0票 0.00%

Disdainful Garbage
您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 21:39:10 | 只看該作者
板凳
發(fā)表于 2025-3-22 02:58:51 | 只看該作者
Cancer Proteomics978-1-59745-169-7Series ISSN 2196-9906 Series E-ISSN 2196-9914
地板
發(fā)表于 2025-3-22 07:38:31 | 只看該作者
PSED II and the Kauffman Firm SurveyThis chapter describes the key elements in tumor biomarker development toward clinical use. In particular, it focuses on the analytical aspects of assay development and how to implement new tumor biomarkers in the clinical setting.
5#
發(fā)表于 2025-3-22 09:06:59 | 只看該作者
6#
發(fā)表于 2025-3-22 16:57:29 | 只看該作者
https://doi.org/10.1007/978-1-59745-169-7Bioinformatics; Cancer Research; Carcinom; Oncology; Proteomics; Translation; classification; diagnostics; p
7#
發(fā)表于 2025-3-22 20:00:45 | 只看該作者
New Feminist Perspectives on Embodiment merited the Nobel Prize were especially revolutionary examples, but mass analyzer design, ion chemistry, ion detection, and data analysis have all seen significant performance advances. In the area of proteomics, the key moment for any of these innovations and advances comes when they are transferr
8#
發(fā)表于 2025-3-22 23:02:48 | 只看該作者
9#
發(fā)表于 2025-3-23 05:14:59 | 只看該作者
https://doi.org/10.1007/978-1-349-22450-0ions, prediction of clinical outcome and monitoring response to cancer treatments. The exciting move toward kinase-targeted therapy has brought new technical challenges in profiling protein kinase genes and proteins as surrogate clinical biomarkers, particularly in light of clinical data correlating
10#
發(fā)表于 2025-3-23 07:58:50 | 只看該作者
New Findings in Long-Wave Research individual. Numerous proteomic technologies are available, and selected ones relevant to development of personalized therapy are described. Cancer biomarkers discovered by proteomics can be used for diagnosis as well as drug targets, thus facilitating the integration of diagnostics and therapeutics
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 11:17
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
杭锦后旗| 四平市| 都安| 吉首市| 莱芜市| 浦县| 昌江| 高要市| 阳江市| 怀安县| 灵丘县| 抚远县| 清涧县| 禄劝| 静宁县| 轮台县| 英德市| 晋中市| 承德市| 鄢陵县| 阿荣旗| 丘北县| 邹城市| 长海县| 镇康县| 华安县| 易门县| 会昌县| 乃东县| 乌拉特中旗| 榆中县| 长葛市| 大新县| 红原县| 洱源县| 葵青区| 保德县| 牡丹江市| 分宜县| 黄梅县| 许昌市|